Triptan migraine treatments and antidepressants: risk of serotonin syndrome

Wooltorton, Eric
October 2006
CMAJ: Canadian Medical Association Journal;10/10/2006, Vol. 175 Issue 8, p873
Academic Journal
The article offers information on the correlation between triptan intake and the risk of serotonin syndrome. A key description of serotonin syndrome is presented. The key function and physiological effect of triptan are discussed. The symptoms of serotonin syndrome are described. Laboratory abnormalities examined from patients taking triptans are outlined.


Related Articles

  • Drug-induced disorders. Holland, Eileen C.; Degruy, Frank V. // American Family Physician;11/1/1997, Vol. 56 Issue 7, p1781 

    Focuses on drug-induced disorders. Common-type of drug-induced disorders; Drug associated with drug-induced problems; Clinical manifestations of drug-induced disorders; Factors that contribute to the development of adverse drug reactions; How to recognize an adverse drug reaction.

  • Strattera: increased risk of suicidal ideation in children and adolescents.  // Reactions Weekly;10/8/2005, Issue 1072, p2 

    Reports on the announcement by Eli Lilly and Co. that the Strattera label for atomoxetine will be updated globally to warn of a possible association between the drug and suicidal ideation in children and adolescents in the U.S. Analysis of adverse events from Strattera clinical trials; Safety...

  • Carboplatin/cisplatin/etoposide.  // Reactions Weekly;9/16/2006, Issue 1119, p8 

    The article presents a case report of a male patient who developed chronic myelomonocytic leukemia after platinum-based antineoplastic therapy, based on a study by K. B. Kim, S. Faderl et al., published in the August 2006 issue of the "Journal of Clinical Pharmacy and Therapeutics." A brief...

  • Fluticasone propionate interaction.  // Reactions Weekly;1/6/2007, Issue 1133, p11 

    The article discusses research being done on various patients receiving ritonavir and lopinavir, who developed Cushing's syndrome during concomitant treatment with fluticasone propionate. It references a study by R. Arrington-Sanders and colleagues, published in the November 2006 issue of...

  • The Systems Biology Approach to Drug Development: Application to Toxicity Assessment of Cardiac Drugs. Rodriguez, B.; Burrage, K.; Gavaghan, D.; Grau, V.; Kohl, P.; Noble, D. // Clinical Pharmacology & Therapeutics;Jul2010, Vol. 88 Issue 1, p130 

    Side effects account for most of the instances of failure of candidate drugs at late stages of development. These development failures contribute to the exorbitant cost of bringing new compounds to market: a single withdrawal can represent a loss of more than $1 billion. Many unwanted actions of...

  • TRIPTANS. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p824 

    The article presents information on triptans, an antimigraine drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • A simple recipe for drug interaction networks earns its stars. Schmatz, Dennis; Friend, Stephen // Nature Genetics;Apr2006, Vol. 38 Issue 4, p405 

    A new study elucidates a drug interaction network using a simple combination of theory and experiments, testing drug combinations on Escherichia coli. The results are elegant, uncovering drug interactions shared within drug classes and providing useful tools for functional classifications of drugs.

  • The Serotonin Syndrome. Boyer, Edward W.; Shannon, Michael // New England Journal of Medicine;3/17/2005, Vol. 352 Issue 11, p1112 

    Discusses the serotonin syndrome, a potentially life-threatening adverse drug reactions that results from therapeutic drug use, intentional self-poisoning, or inadvertent interactions between drugs. How the features of serotonin syndrome are critical to an understanding of the disorder;...

  • Prescribing information in 26 countries: a comparative study. Reggi, V.; Balocco-Mattavelli, R.; Bonati, M.; Breton, I.; Figueras, A.; Jambert, E.; Kopp, C.; Montane, E.; Rägo, L.; Rocchi, F. // European Journal of Clinical Pharmacology;Aug2003, Vol. 59 Issue 4, p263 

    This study was set up to document the variability of prescribing information from different sources concerning indications, side effects and cautions of selected drugs. An original method to measure the degree of information agreement among different written materials, such as summaries of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics